Advertisement
Screener

PROCEPT BioRobotics Corporation (PRCT) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

PROCEPT BioRobotics Corporation Cash Flow Breakdown

Cash flow breakdown shows where PROCEPT BioRobotics Corporation's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $48.98M went out.
  • Fiscal year ended 2025-12-31: from investing, $9.36M went out.
  • Fiscal year ended 2025-12-31: from financing, $11.19M came in.
  • Fiscal year ended 2025-12-31: change in cash, $47.22M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew shares soldNot split outChange in cash
2025-12-31-$48.98M-$9.36M$0.00$11.19M*-$47.22M
2024-12-31-$99.21M-$4.41M$0.00*$164.52M$15.60M*$76.50M
2023-12-31-$108.00M-$25.21M$0.00*$161.71M$6.09M*$34.59M
2022-12-31-$80.38M-$2.65M-$51.00M*$0.00$54.61M*-$79.42M
2021-12-31-$57.33M-$592.00K$0.00*$0.00$262.12M*$204.19M
2020-12-31-$48.34M-$233.00K$2.29M$104.48M*$58.20M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$19.25M*-$2.95M*$183.00K*$4.31M*
2026-03-31-$38.13M-$2.91M$222.00K-$40.86M
2025-12-31-$10.33M*-$1.85M*$1.58M*$2.86M*
2025-09-30-$6.63M*-$2.87M*$1.08M*
2025-06-30-$15.04M*-$2.80M*$873.00K*$3.50M*
2025-03-31-$16.98M-$1.84M$1.30M-$17.52M
2024-12-31-$32.39M*-$1.17M*$164.52M*$6.00M*
2024-09-30-$18.80M*-$246.00K*$1.72M*
2024-06-30-$15.74M*-$1.04M*$3.17M*$2.12M*
2024-03-31-$32.29M-$1.95M$2.59M-$31.65M
2023-12-31-$24.79M*-$8.71M*$0.00*$2.87M*
2023-09-30-$18.94M*-$5.78M*$159.99M*$2.13M*
2023-06-30-$28.34M*-$5.37M*$713.00K*$1.72M*
2023-03-31-$35.93M-$5.34M$380.00K-$40.89M
2022-12-31-$25.17M*-$866.00K*$0.00*-$1.32M*
2022-09-30-$19.85M*-$1.51M*-$1.29M*$2.07M*
2022-06-30-$17.13M*-$218.00K*$1.57M*$1.29M*
2022-03-31-$18.23M-$55.00K$1.29M-$17.00M
2021-12-31-$16.48M*-$332.00K*$0.00*$644.00K*
2021-09-30-$12.75M*-$111.00K*$0.00*$174.12M*
2021-06-30-$12.91M*-$110.00K*$1.42M*$84.71M*
2021-03-31-$15.20M-$39.00K$1.23M-$14.01M
2020-12-31-$13.45M*-$9.00K*$237.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
SpyGlass Pharma, Inc. (SGP)United States$0.925B
IRADIMED CORP (IRMD)United States$1.089B52.92
ARTIVION, INC. (AORT)United States$1.123B-345.09
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B